Praxis Precision Medicines, Inc.
PRAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.61 | -5.22 | -0.24 | -0.95 |
| FCF Yield | -5.56% | -6.07% | -6.61% | -3.65% |
| EV / EBITDA | -13.74 | -9.82 | -8.47 | -20.71 |
| Quality | ||||
| ROIC | -22.78% | -18.78% | -16.97% | -14.31% |
| Gross Margin | 0.00% | 0.00% | 0.00% | -654.23% |
| Cash Conversion Ratio | 0.88 | 0.77 | 0.76 | 0.96 |
| Growth | ||||
| Revenue 3-Year CAGR | 56.90% | 74.39% | 128.25% | 2,044,960.49% |
| Free Cash Flow Growth | -18.14% | -3.96% | 6.08% | -104.08% |
| Safety | ||||
| Net Debt / EBITDA | 2.02 | 2.06 | 2.20 | 3.35 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -42.16 | -41.18 | -33.91 | -20.03 |